Clinical Trial Update: Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder [Phase 1]

View source ↗

Summary

Phase 1 study comparing plasma concentration changes between two FK949E tablet formulations in adults with Major depressive disorder; the trial assesses pharmac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• FK949E

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED